The neglected tropical disease affects thousands of people and is mostly fatal. Now, new research co-authored by Northeastern chemistry professor Michael Pollastri has identified hundreds of compounds that could lead to a cure.
During a keynote address at Northeastern on Tuesday, an epidemiologist at Boston Medical Center who has administered care to Ebola patients in Sierra Leone, noted that more help is needed in Africa to provide healthcare services, adding that “We need help with everything.”
A group of Northeastern students has joined the crusade to bring an end to the 17 neglected tropical diseases that affect more than 1 billion people around the world. Called NEU END7, the group has been working since October to raise awareness of NTDs and help eradicate the seven most common tropical infections by 2020.
In one of the largest science-research-based crowdfunding campaigns to date, Northeastern University College of Science associate professor Michael Pollastri raised $25,031.
Professor Michael Pollastri is creating a new platform to share data with international researchers focused on neglected tropical diseases.
The secrecy model that dominates drug discovery doesn’t work for neglected tropical diseases. Associate Professor Michael Pollastri hopes to shift that paradigm with a new platform for secure data-sharing.
Listen to chemistry professor Michael Pollastri talk about his work finding treatments for NTDs.
Professor Michael Pollastri, a chemistry professor in the College of Science at Northeastern University, talked about NTDs – neglected tropical diseases.
Ninety percent of global healthcare and medical research money is spent on diseases that affect only 10 percent of the population, according to Michael Pollastri, a professor of chemistry and chemical biology who spoke at the College of Science Colloquium last Friday.